Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 26, Issue 12, 2011, Pages 4047-4054

  Liao, Chia Te ^a   Kao, Tze Wah ^a   Chou, Yu Hsiang ^a   Wu, Ming Shiou ^a   Chen, Yung Ming ^a   Chuang, Hsueh Fang ^a   Hung, Kuan Yu ^a   Chu, Tzong Shinn ^a   Wu, Kwan Dun ^a   Tsai, Tun Jun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

cardiovascular disease; metabolic syndrome; peritoneal dialysis; survival

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART DEATH; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN DEFICIENCY; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERITONEAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 82255185532     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr175     Document Type: Article

References (38)

1. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615 (Pubitemid 29297538)
2. Muntner P, He J, Astor BC et al. Traditional and nontraditional risk factors predict coronary artery disease in chronic kidney disease: results from atherosclerosis risk in communities study. J Am Soc Nephrol 2005; 16: 529-538 (Pubitemid 41725151)
3. Kendrick J, Chonchol MB. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat Clin Pract Nephrol 2008; 4: 672-681
4. Stenvinkel P, Carrero JJ, Axelsson J et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patients: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008; 3: 505-521
5. Eckel RH, Grundy SM, Simmer PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428 (Pubitemid 40523737)
6. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140 (Pubitemid 41716445)
7. Chen J, Gu D, Chen CS et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 2007; 22: 1100-1106 (Pubitemid 46523424)
8. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689 (Pubitemid 32893993)
9. Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and metaanalysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414 (Pubitemid 46135879)
10. Johnson DW, Armstrong K, Campbell SB et al. Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 2007; 12: 391-398 (Pubitemid 47075413)
11. Jiang N, Qian J, Lin A et al. Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease. Blood Purif 2008; 26: 423-428
12. Park SH, Lindholm B. Definition of metabolic syndrome in peritoneal dialysis. Perit Dial Int 2009; 29: S137-S144
13. Davies SJ, Phillips L, Naish PF et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046-1051 (Pubitemid 32378346)
14. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
15. Kahn R, Buse J, Ferrannini E et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304 (Pubitemid 41242486)
16. World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications, 2000
17. Anuurad E, Shiwaku K, Nogi A et al. The new BMI criteria for Asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health 2003; 45: 335-343 (Pubitemid 38036188)
18. Li PK, Kwan BC, Ko GT et al. Treatment of metabolic syndrome in peritoneal dialysis patients. Perit Dial Int 2009; 29: S149-S152
19. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-S69
20. Wang AY, Lam CW, Chan IH et al. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers. Nephrol Dial Transplant 2009; 24: 3826-3833
21. Engelstein ED, Zipes DP. Sudden cardiac death. In: Alexander RW, ed. Hurst's the Heart, Arteries and Veins. New York, NY: McGraw-Hill; 1998:1081-1112
22. Szeto CC, Chow KM, Kwan BC et al. New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis 2007; 49: 524-532 (Pubitemid 46441605)
23. Park JT, Chang TI, Kim DK et al. Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2010; 25: 599-604
24. Habib AN, Baird BC, Leypoldt JK et al. The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant 2006; 21: 2881-2892 (Pubitemid 44542246)
25. Kahn R. Metabolic syndrome-what is the clinical usefulness? Lancet 2008; 371: 1892-1893
26. Sattar N, McConnachie A, Shaper AG et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008; 371: 1927-1935
27. Snyder JJ, Foley RN, Gilbertson DT et al. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 2003; 64: 1838-1844 (Pubitemid 37323715)
28. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 2003; 14: 2894-2901 (Pubitemid 37305652)
29. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163
30. Axelsson J, Rashid Qureshi A, Suliman ME et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004; 80: 1222-1229 (Pubitemid 41350682)
31. Choi SJ, Kim NR, Hong SA et al. Changes in body fat mass in patients after starting peritoneal dialysis. Perit Dial Int 2011; 31: 67-73
32. Lameire N, Matthys D, Matthys E et al. Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol 1988; 30: S53-S58
33. de Moraes TP, Pecoits-Filho R. Metabolic impact of peritoneal dialysis. Contrib Nephrol 2009; 163: 117-123
34. Dandona P, Aljada A, Chaudhuri A et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-1454 (Pubitemid 40396812)
35. Shinohara K, Shoji T, Emoto M et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with endstage renal disease. J Am Soc Nephrol 2002; 13: 1894-1900 (Pubitemid 34700615)
36. Honda H, Qureshi AR, Heimbürger O et al. Serum albumin, Creactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148 (Pubitemid 41828276)
37. de Mutsert R, Grootendorst DC, Axelsson J et al. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant 2008; 23: 2957-2964
38. Pecoits-Filho R, Stenvinkel P, Wang AY et al. Chronic inflammation in peritoneal dialysis: the search for the holy grail? Perit Dial Int 2004; 24: 327-339 (Pubitemid 39206627)